Independent analysis puts a MKM dulaglutide lot at 98.2%, against 96.7% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Coverage naming MKM
Reporting from across the Journal that names Xi'an Mokemei Biotechnology Co., Ltd., or that bears directly on the questions its dossier leaves open. The dossier itself — the testing record, the correspondence log and the verification box — is here.
Independent analysis puts a MKM cagrilintide lot at 97.3%, against 95.9% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
Independent analysis puts a MKM survodutide lot at 96.5%, against 95.5% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Independent analysis puts a MKM liraglutide lot at 99.0%, against 97.4% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
What changed at MKM in September, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a MKM dulaglutide lot at 99.2%, against 96.7% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
What changed at MKM in May, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a MKM liraglutide lot at 96.2%, against 94.9% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
MKM declines, for the 16th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at MKM in July, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a MKM retatrutide lot at 95.5%, against 92.8% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
What changed at MKM in June, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at MKM in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
MKM declines, for the 16th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
MKM declines, for the 19th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
MKM declines, for the 19th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a MKM survodutide lot at 97.0%, against 95.7% on the certificate
The result is unremarkable. What the report omits is not.
What changed at MKM in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Independent analysis puts a MKM cagrilintide lot at 98.9%, against 94.9% on the certificate
A reminder that a purity figure is the output of a method, and that methods differ.